Selected research
Industry Research
AI In Clinical Trials Industry Research Report 2026
Market perspective
The global AI In Clinical Trials market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI In Clinical Trials market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI In Clinical Trials market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI In Clinical Trials market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI In Clinical Trials include Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate and Neuroute, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI In Clinical Trials market in terms of revenue (US$ million) and, where applicable, service volume (Unit), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Unit) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI In Clinical Trials.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI In Clinical Trials Market by Company
Intel
The International Business Machines Corporation(IBM)
Koninklijke Philips N.V.
ConcertAl
Saama Technologies LLC
Samaa Technologies
Owkin Inc.
Numerate
Neuroute
AiCure
Ardigen
Unlearn Al
PathAl
Exscentia
Aitia Infotech Pvt Ltd.
Euretos
VeriSIM Life
Envisagenics
NURITAs
BioSymetrics
BioAge Labs lInc
AI In Clinical Trials Segment by Type
Software
Service
AI In Clinical Trials Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organization
Other
AI In Clinical Trials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI In Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI In Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI In Clinical Trials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI In Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Software
- Service
Applications
- Pharmaceutical and Biotechnology Companies
- Contract Research Organization
- Other
Companies covered
- Intel
- The International Business Machines Corporation(IBM)
- Koninklijke Philips N.V.
- ConcertAl
- Saama Technologies LLC
- Samaa Technologies
- Owkin Inc.
- Numerate
- Neuroute
- AiCure
- Ardigen
- Unlearn Al
- PathAl
- Exscentia
- Aitia Infotech Pvt Ltd.
- Euretos
- VeriSIM Life
- Envisagenics
- NURITAs
- BioSymetrics
- BioAge Labs lInc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI In Clinical Trials by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Software
- 2.2.3 Service
- 2.3 AI In Clinical Trials by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biotechnology Companies
- 2.3.3 Contract Research Organization
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 AI In Clinical Trials Breakdown Data by Type
- 3.1 Global AI In Clinical Trials Historic Market Size by Type (2021-2026)
- 3.2 Global AI In Clinical Trials Forecasted Market Size by Type (2027-2032)
4 AI In Clinical Trials Breakdown Data by Application
- 4.1 Global AI In Clinical Trials Historic Market Size by Application (2021-2026)
- 4.2 Global AI In Clinical Trials Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI In Clinical Trials Market Perspective (2021-2032)
- 5.2 Global AI In Clinical Trials Growth Trends by Region
- 5.2.1 Global AI In Clinical Trials Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI In Clinical Trials Historic Market Size by Region (2021-2026)
- 5.2.3 AI In Clinical Trials Forecasted Market Size by Region (2027-2032)
- 5.3 AI In Clinical Trials Market Dynamics
- 5.3.1 AI In Clinical Trials Industry Trends
- 5.3.2 AI In Clinical Trials Market Drivers
- 5.3.3 AI In Clinical Trials Market Challenges
- 5.3.4 AI In Clinical Trials Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI In Clinical Trials Players by Revenue
- 6.1.1 Global Top AI In Clinical Trials Players by Revenue (2021-2026)
- 6.1.2 Global AI In Clinical Trials Revenue Market Share by Players (2021-2026)
- 6.2 Global AI In Clinical Trials Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI In Clinical Trials Head Office and Area Served
- 6.4 Global AI In Clinical Trials Players, Product Type & Application
- 6.5 Global AI In Clinical Trials Manufacturers Established Date
- 6.6 Global AI In Clinical Trials Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI In Clinical Trials Market Size (2021-2032)
- 7.2 North America AI In Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI In Clinical Trials Market Size by Country (2021-2026)
- 7.4 North America AI In Clinical Trials Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI In Clinical Trials Market Size (2021-2032)
- 8.2 Europe AI In Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI In Clinical Trials Market Size by Country (2021-2026)
- 8.4 Europe AI In Clinical Trials Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI In Clinical Trials Market Size (2021-2032)
- 9.2 Asia-Pacific AI In Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI In Clinical Trials Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI In Clinical Trials Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI In Clinical Trials Market Size (2021-2032)
- 10.2 South America AI In Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI In Clinical Trials Market Size by Country (2021-2026)
- 10.4 South America AI In Clinical Trials Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI In Clinical Trials Market Size (2021-2032)
- 11.2 Middle East & Africa AI In Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI In Clinical Trials Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI In Clinical Trials Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Intel
- 12.1.1 Intel Company Information
- 12.1.2 Intel Business Overview
- 12.1.3 Intel Revenue in AI In Clinical Trials Business (2021-2026)
- 12.1.4 Intel AI In Clinical Trials Product Portfolio
- 12.1.5 Intel Recent Developments
- 12.2 The International Business Machines Corporation(IBM)
- 12.2.1 The International Business Machines Corporation(IBM) Company Information
- 12.2.2 The International Business Machines Corporation(IBM) Business Overview
- 12.2.3 The International Business Machines Corporation(IBM) Revenue in AI In Clinical Trials Business (2021-2026)
- 12.2.4 The International Business Machines Corporation(IBM) AI In Clinical Trials Product Portfolio
- 12.2.5 The International Business Machines Corporation(IBM) Recent Developments
- 12.3 Koninklijke Philips N.V.
- 12.3.1 Koninklijke Philips N.V. Company Information
- 12.3.2 Koninklijke Philips N.V. Business Overview
- 12.3.3 Koninklijke Philips N.V. Revenue in AI In Clinical Trials Business (2021-2026)
- 12.3.4 Koninklijke Philips N.V. AI In Clinical Trials Product Portfolio
- 12.3.5 Koninklijke Philips N.V. Recent Developments
- 12.4 ConcertAl
- 12.4.1 ConcertAl Company Information
- 12.4.2 ConcertAl Business Overview
- 12.4.3 ConcertAl Revenue in AI In Clinical Trials Business (2021-2026)
- 12.4.4 ConcertAl AI In Clinical Trials Product Portfolio
- 12.4.5 ConcertAl Recent Developments
- 12.5 Saama Technologies LLC
- 12.5.1 Saama Technologies LLC Company Information
- 12.5.2 Saama Technologies LLC Business Overview
- 12.5.3 Saama Technologies LLC Revenue in AI In Clinical Trials Business (2021-2026)
- 12.5.4 Saama Technologies LLC AI In Clinical Trials Product Portfolio
- 12.5.5 Saama Technologies LLC Recent Developments
- 12.6 Samaa Technologies
- 12.6.1 Samaa Technologies Company Information
- 12.6.2 Samaa Technologies Business Overview
- 12.6.3 Samaa Technologies Revenue in AI In Clinical Trials Business (2021-2026)
- 12.6.4 Samaa Technologies AI In Clinical Trials Product Portfolio
- 12.6.5 Samaa Technologies Recent Developments
- 12.7 Owkin Inc.
- 12.7.1 Owkin Inc. Company Information
- 12.7.2 Owkin Inc. Business Overview
- 12.7.3 Owkin Inc. Revenue in AI In Clinical Trials Business (2021-2026)
- 12.7.4 Owkin Inc. AI In Clinical Trials Product Portfolio
- 12.7.5 Owkin Inc. Recent Developments
- 12.8 Numerate
- 12.8.1 Numerate Company Information
- 12.8.2 Numerate Business Overview
- 12.8.3 Numerate Revenue in AI In Clinical Trials Business (2021-2026)
- 12.8.4 Numerate AI In Clinical Trials Product Portfolio
- 12.8.5 Numerate Recent Developments
- 12.9 Neuroute
- 12.9.1 Neuroute Company Information
- 12.9.2 Neuroute Business Overview
- 12.9.3 Neuroute Revenue in AI In Clinical Trials Business (2021-2026)
- 12.9.4 Neuroute AI In Clinical Trials Product Portfolio
- 12.9.5 Neuroute Recent Developments
- 12.10 AiCure
- 12.10.1 AiCure Company Information
- 12.10.2 AiCure Business Overview
- 12.10.3 AiCure Revenue in AI In Clinical Trials Business (2021-2026)
- 12.10.4 AiCure AI In Clinical Trials Product Portfolio
- 12.10.5 AiCure Recent Developments
- 12.11 Ardigen
- 12.11.1 Ardigen Company Information
- 12.11.2 Ardigen Business Overview
- 12.11.3 Ardigen Revenue in AI In Clinical Trials Business (2021-2026)
- 12.11.4 Ardigen AI In Clinical Trials Product Portfolio
- 12.11.5 Ardigen Recent Developments
- 12.12 Unlearn Al
- 12.12.1 Unlearn Al Company Information
- 12.12.2 Unlearn Al Business Overview
- 12.12.3 Unlearn Al Revenue in AI In Clinical Trials Business (2021-2026)
- 12.12.4 Unlearn Al AI In Clinical Trials Product Portfolio
- 12.12.5 Unlearn Al Recent Developments
- 12.13 PathAl
- 12.13.1 PathAl Company Information
- 12.13.2 PathAl Business Overview
- 12.13.3 PathAl Revenue in AI In Clinical Trials Business (2021-2026)
- 12.13.4 PathAl AI In Clinical Trials Product Portfolio
- 12.13.5 PathAl Recent Developments
- 12.14 Exscentia
- 12.14.1 Exscentia Company Information
- 12.14.2 Exscentia Business Overview
- 12.14.3 Exscentia Revenue in AI In Clinical Trials Business (2021-2026)
- 12.14.4 Exscentia AI In Clinical Trials Product Portfolio
- 12.14.5 Exscentia Recent Developments
- 12.15 Aitia Infotech Pvt Ltd.
- 12.15.1 Aitia Infotech Pvt Ltd. Company Information
- 12.15.2 Aitia Infotech Pvt Ltd. Business Overview
- 12.15.3 Aitia Infotech Pvt Ltd. Revenue in AI In Clinical Trials Business (2021-2026)
- 12.15.4 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Portfolio
- 12.15.5 Aitia Infotech Pvt Ltd. Recent Developments
- 12.16 Euretos
- 12.16.1 Euretos Company Information
- 12.16.2 Euretos Business Overview
- 12.16.3 Euretos Revenue in AI In Clinical Trials Business (2021-2026)
- 12.16.4 Euretos AI In Clinical Trials Product Portfolio
- 12.16.5 Euretos Recent Developments
- 12.17 VeriSIM Life
- 12.17.1 VeriSIM Life Company Information
- 12.17.2 VeriSIM Life Business Overview
- 12.17.3 VeriSIM Life Revenue in AI In Clinical Trials Business (2021-2026)
- 12.17.4 VeriSIM Life AI In Clinical Trials Product Portfolio
- 12.17.5 VeriSIM Life Recent Developments
- 12.18 Envisagenics
- 12.18.1 Envisagenics Company Information
- 12.18.2 Envisagenics Business Overview
- 12.18.3 Envisagenics Revenue in AI In Clinical Trials Business (2021-2026)
- 12.18.4 Envisagenics AI In Clinical Trials Product Portfolio
- 12.18.5 Envisagenics Recent Developments
- 12.19 NURITAs
- 12.19.1 NURITAs Company Information
- 12.19.2 NURITAs Business Overview
- 12.19.3 NURITAs Revenue in AI In Clinical Trials Business (2021-2026)
- 12.19.4 NURITAs AI In Clinical Trials Product Portfolio
- 12.19.5 NURITAs Recent Developments
- 12.20 BioSymetrics
- 12.20.1 BioSymetrics Company Information
- 12.20.2 BioSymetrics Business Overview
- 12.20.3 BioSymetrics Revenue in AI In Clinical Trials Business (2021-2026)
- 12.20.4 BioSymetrics AI In Clinical Trials Product Portfolio
- 12.20.5 BioSymetrics Recent Developments
- 12.21 BioAge Labs lInc
- 12.21.1 BioAge Labs lInc Company Information
- 12.21.2 BioAge Labs lInc Business Overview
- 12.21.3 BioAge Labs lInc Revenue in AI In Clinical Trials Business (2021-2026)
- 12.21.4 BioAge Labs lInc AI In Clinical Trials Product Portfolio
- 12.21.5 BioAge Labs lInc Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst